未登录

E

Eric S. Kilpatrick

university of york - uk

H指数:41

被引数:6,435

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Using nephropathy as an outcome to determine the HbA1c diagnostic threshold for type 2 diabetes

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS

IF3.4

2024-04-011

PRE

The effectiveness of blood glucose and blood ketone measurement in identifying significant acidosis in diabetic ketoacidosis patients

血糖和血酮测定在识别糖尿病酮症酸中毒患者严重酸中毒中的有效性

DIABETOLOGY & METABOLIC SYNDROME

IF3.9

2023-10-130

OAAI

Comparing Detection of Diabetic Retinopathy by Three Artificial Intelligence Platforms in Subjects Not Known to Have Diabetes

IF7.5

2023-06-200

PRE

Establishing Pragmatic Analytical Performance Specifications for Blood Beta-Hydroxybutyrate Testing

建立用于血液 β-羟基丁酸酯测试的实用分析性能规范

CLINICAL CHEMISTRY

IF6.3

2023-03-152

OAAI

Cardiac Troponin as a Marker of Heart Failure Risk in Diabetes

CLINICAL CHEMISTRY

IF6.3

2022-07-280

OA

Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis (vol 45, pg 267, 2022)

IF16.6

2022-03-030

OA

Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis

IF16.6

2022-01-1722

OA

The retinopathy-derived HbA1c threshold of 6.5% for type 2 diabetes also captures the risk of diabetic nephropathy in NHANES

DIABETES OBESITY & METABOLISM

IF5.7

2021-06-0910

OAAI

Using clinical guidelines to assess the potential value of laboratory medicine in clinical decision-making

BIOCHEMIA MEDICA

IF1.8

2021-02-168

OAAI

Diagnosing type 2 diabetes using Hemoglobin A1c: a systematic review and meta-analysis of the diagnostic cutpoint based on microvascular complications

使用血红蛋白A1c诊断2型糖尿病: 基于微血管并发症的诊断切点的系统评价和荟萃分析

ACTA DIABETOLOGICA

IF2.9

2020-11-0313

OAAI

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2019-04-0224

OAAI

Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study

CLINICAL ENDOCRINOLOGY

IF2.4

2019-04-0276

OAAI

Association of Vitamin D Metabolites With Embryo Development and Fertilization in Women With and Without PCOS Undergoing Subfertility Treatment

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2019-01-2930

OAAI

The Effect of High Dose Isoflavone Supplementation on Serum Reverse T3 in Euthyroid Men With Type 2 Diabetes and Post-menopausal Women

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2018-11-229

OAAI

Development of a novel risk prediction and risk stratification score for polycystic ovary syndrome

CLINICAL ENDOCRINOLOGY

IF2.4

2018-11-1512

OAAI

Dynamic Change in Insulin Resistance Induced by Free Fatty Acids Is Unchanged Though Insulin Sensitivity Improves Following Endurance Exercise in PCOS

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2018-10-059

OAAI

The Effect of Phytoestrogen on Thyroid in Subclinical Hypothyroidism: Randomized, Double Blind, Crossover Study

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2018-09-1110

OAAI

The Effect of a Simulated Commercial Flight Environment With Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants With Type 2 Diabetes - A Cross-Over Study (vol 9, pg 26, 2018)

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2018-06-070

OAAI

Electrochemical measurement of antibody-antigen recognition biophysics: Thermodynamics and kinetics of human chorionic gonadotropin (hCG) binding to redox-tagged antibodies

JOURNAL OF ELECTROANALYTICAL CHEMISTRY

IF4.1

2018-06-018

OAAI

Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome

SCIENTIFIC REPORTS

IF3.9

2018-02-2616

OAAI